PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Myeloperoxidase 16,181 Target Target Elastase 13,875 671 0.04 -0.96 0.05 0.74
CD1A 2,739 Target Disease Infection 766,637 240 0.01 -0.96 0.09 0.57
ACRP30 102 Target Disease Cholesterol 182,390 9 0.00 -0.95 0.09 0.58
CEA 17,022 Target Disease Stroke 146,992 1,358 0.03 -0.95 0.08 0.65
Antithrombin 13,773 Target Target Bivalirudin 891 75 0.02 -0.95 0.08 0.69
CCL4 5,638 Target Target CXCL10/IP-10 114 10 0.01 -0.95 0.09 0.68
Angiotensin Converting Enzyme 31,674 Target Disease Albuminuria 6,831 509 0.03 -0.95 0.07 0.70
CCL19 658 Target Target CXCL10 2,386 47 0.04 -0.95 0.07 0.75
Collagen 138,882 Target Target bFGF 9,327 791 0.02 -0.95 0.08 0.64
CD4 112,219 Target Target CCL3 1,427 127 0.01 -0.95 0.09 0.62
ANGPTL4 289 Target Disease Cholesterol 182,390 26 0.00 -0.95 0.09 0.59
Collagenase-3 367 Target Disease Osteoarthritis 36,287 33 0.01 -0.95 0.09 0.64
ACAD8 11 Target Disease Cholesterol 182,390 1 0.00 -0.95 0.09 0.57
744.1 22 Target Disease Inflammation 252,734 2 0.00 -0.95 0.09 0.57
DC-CK1 22 Target Disease Inflammation 252,734 2 0.00 -0.95 0.09 0.57
CD4 112,219 Target Drug Atovaquone (Mepron)- FDA 11 1 0.00 -0.95 0.09 0.58
Metabotropic Glutamate Receptor 3 55 Target Disease Pain 409,851 5 0.00 -0.95 0.09 0.56
ACAD8 11 Target Disease Anemia 81,663 1 0.00 -0.95 0.09 0.59
ACAD8 11 Target Disease Prostate Cancer 71,064 1 0.00 -0.95 0.09 0.59
ADSF 11 Target Disease Seizures 66,465 1 0.00 -0.95 0.09 0.59
DC-CK1 22 Target Disease Arthritis 128,324 2 0.00 -0.95 0.09 0.58
744.1 22 Target Disease Heart Disease 118,291 2 0.00 -0.95 0.09 0.58
DC-CK1 22 Target Disease Rheumatoid Arthritis 78,952 2 0.00 -0.95 0.09 0.59
Neuropeptide S Receptor 77 Target Disease Inflammation 252,734 7 0.00 -0.95 0.09 0.57
CD34 24,598 Target Disease Myeloma Multiple 11 1 0.00 -0.95 0.09 0.61
ACAD8 11 Target Disease Dehydration 21,928 1 0.00 -0.95 0.09 0.62
BAFFR 44 Target Disease Rheumatoid Arthritis 78,952 4 0.00 -0.95 0.09 0.60
CEA 17,022 Target Drug Aphrodyne (Yohimbine)- FDA 11 1 0.00 -0.95 0.09 0.62
ACAD8 11 Target Target APOE 12,771 1 0.00 -0.95 0.09 0.63
744.1 22 Target Disease Cardiac Arrest 20,700 2 0.00 -0.95 0.09 0.62
Glucocorticoid Receptor 10,306 Target Drug Aphrodyne (Yohimbine)- FDA 11 1 0.00 -0.95 0.09 0.63
ADSF 11 Target Target D-Dimer 6,185 1 0.00 -0.95 0.09 0.65
ERK1 18,374 Target Target DEP-1 88 8 0.01 -0.95 0.09 0.64
CD4 112,219 Target Disease Inflammation 252,734 7,264 0.04 -0.95 0.06 0.66
A1AT 329 Target Disease Liver Disease 49,817 30 0.01 -0.95 0.09 0.63
Artemin 184 Target Disease Carcinoma 433,099 17 0.00 -0.95 0.09 0.57
CXCL16 341 Target Target CCL2 3,560 29 0.03 -0.95 0.09 0.72
CCL7 274 Target Target Eotaxin 2,457 23 0.03 -0.95 0.08 0.73
Phosphodiesterase 4b 54 Target Disease Cancer 1,053,491 5 0.00 -0.95 0.09 0.54
CAMK4 43 Target Disease Inflammation 252,734 4 0.00 -0.95 0.09 0.57
Aldosterone Receptor 528 Target Target Collagen 138,882 49 0.01 -0.95 0.09 0.60
Myeloperoxidase 16,181 Target Target Cathepsin G 1,613 138 0.03 -0.95 0.09 0.70
Acetyl-Coa Carboxylase 1 118 Target Disease Liver Disease 49,817 11 0.00 -0.95 0.09 0.62
ACVR1B 23 Target Target BMPR1A 279 2 0.02 -0.95 0.09 0.76
Insulin-Like Growth Factor 1 Receptor 1,052 Target Disease Breast Cancer 173,695 98 0.01 -0.95 0.09 0.61
Epigen 27 Target Target beta-Cellulin 17 1 0.05 -0.95 0.06 0.83
Myeloperoxidase 16,181 Target Drug Kaempferitrin 32 3 0.00 -0.95 0.09 0.64
CAPG 85 Target Disease Breast Cancer 173,695 8 0.00 -0.95 0.09 0.58
Atosiban 274 Target Drug Atropine (Atropen)- FDA 11 1 0.02 -0.95 0.09 0.74
Atosiban 274 Target Drug Atropen (Atropine)- FDA 11 1 0.02 -0.95 0.09 0.74
CCL19 658 Target Target CCL2 3,560 53 0.03 -0.95 0.08 0.74
Collagen 138,882 Target Target BMP-4 1,255 118 0.01 -0.95 0.09 0.61
CAMK1D 21 Target Disease Breast Cancer 173,695 2 0.00 -0.95 0.10 0.57
CAMK2D 21 Target Disease Epilepsy 71,172 2 0.00 -0.95 0.10 0.59
CAMK2D 21 Target Disease Seizures 66,465 2 0.00 -0.95 0.10 0.60
Cathepsin G 1,613 Target Target Alpha-1 AntiChymotrypsin 1,460 75 0.05 -0.95 0.05 0.78
Cytokeratin 8 587 Target Disease Breast Cancer 173,695 56 0.01 -0.95 0.10 0.60
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
AKT3 293 Target Disease Breast Cancer 173,695 28 0.00 -0.95 0.10 0.59
Hyaluronidase-1 52 Target Disease Inflammation 252,734 5 0.00 -0.95 0.10 0.57
Androgen Receptor 12,918 Target Target Estrogen Receptor Beta 1,924 163 0.03 -0.95 0.08 0.71
CCL4 5,638 Target Target CXCL10 2,386 165 0.04 -0.95 0.07 0.75
CXCL7 76 Target Target CCL3 1,427 7 0.02 -0.95 0.09 0.73
A1AT 329 Target Disease Inflammation 252,734 32 0.00 -0.95 0.10 0.58
Adenosine A3 Receptor 164 Target Disease Inflammation 252,734 16 0.00 -0.95 0.10 0.58
ACY1 51 Target Disease Lung Cancer 91,416 5 0.00 -0.95 0.10 0.60
ApoE2 517 Target Disease Hyperlipoproteinemia 2,954 44 0.04 -0.95 0.09 0.74
CXCL16 341 Target Target CXCL9 1,016 26 0.04 -0.95 0.08 0.77
AFP 9,751 Target Target Chorionic Gonadotropin beta 936 86 0.03 -0.95 0.09 0.71
ADRBK1 10 Target Disease Infection 766,637 1 0.00 -0.95 0.10 0.54
4-1BB Receptor 20 Target Disease Infection 766,637 2 0.00 -0.95 0.10 0.55
ADRBK1 10 Target Disease Cholesterol 182,390 1 0.00 -0.95 0.10 0.57
ADRBK1 10 Target Disease Hepatitis 163,842 1 0.00 -0.95 0.10 0.57
ADRBK1 10 Target Disease Stroke 146,992 1 0.00 -0.95 0.10 0.58
BRSK1 20 Target Disease Breast Cancer 173,695 2 0.00 -0.95 0.10 0.58
ADRBK1 10 Target Disease Malaria 56,215 1 0.00 -0.95 0.10 0.60
CEA 17,022 Target Target CA 50 1,293 121 0.03 -0.95 0.09 0.69
Calmodulin 25,240 Target Target ADRBK1 10 1 0.00 -0.95 0.10 0.61
ADRBK1 10 Target Disease Attention Deficit Hyperactivity Disorder 14,687 1 0.00 -0.95 0.10 0.63
Calmodulin 25,240 Target Target BRSK1 20 2 0.00 -0.95 0.10 0.62
Glucocorticoid Receptor 10,306 Target Target ADRBK1 10 1 0.00 -0.95 0.10 0.64
CD4 112,219 Target Target Sphingosine 1-Phosphate Receptor 1 150 15 0.00 -0.95 0.10 0.60
CD68 6,424 Target Target ADRBK1 10 1 0.00 -0.95 0.10 0.65
ADRBK1 10 Target Disease Yellow Fever 4,081 1 0.00 -0.95 0.10 0.66
CNTF 1,613 Target Target ADRBK1 10 1 0.01 -0.95 0.10 0.69
EPHB4 329 Target Target EPHA2 532 21 0.05 -0.95 0.06 0.80
CD4 112,219 Target Target CCL5 2,002 199 0.01 -0.95 0.10 0.63
CCL4 5,638 Target Target CXCL2 750 68 0.03 -0.95 0.09 0.73
AACT 109 Target Target APOE 12,771 11 0.01 -0.95 0.10 0.66
C7 7,027 Target Disease Pain 409,851 704 0.01 -0.95 0.10 0.60
A1M 59 Target Disease Proteinuria 28,803 6 0.00 -0.95 0.10 0.63
CD68 6,424 Target Target CD14 9,941 408 0.05 -0.95 0.06 0.75
APOA2 118 Target Target APOE 12,771 12 0.01 -0.95 0.10 0.66
DAPK1 205 Target Disease Leukemia 162,805 21 0.00 -0.95 0.10 0.59
CCL7 274 Target Target CXCL3 145 10 0.05 -0.95 0.07 0.80
CCL19 658 Target Target CCL5 2,002 52 0.05 -0.95 0.08 0.77
CCL8 197 Target Target CCL1 220 11 0.05 -0.95 0.06 0.81
CCL19 658 Target Disease Cancer 1,053,491 68 0.00 -0.95 0.10 0.55
Aldosterone Receptor 528 Target Drug Apresoline (Hydralazine)- FDA 20 2 0.02 -0.95 0.10 0.73
CXCL10/IP-10 114 Target Target CCL3 1,427 11 0.03 -0.95 0.10 0.74